Automating insulin delivery for critically ill patients

CLINICIP projectThousands die or suffer prolonged illness every year, simply because intensive care units are unable to monitor their patients' glucose levels during recovery. One EU project may have solved the problem.

Every year, thousands of intensive care unit (ICU) patients across Europe either die or stay sick for longer than necessary. The cause is the fact that many ICUs cannot easily control the glucose levels in each patient's blood.

"Studies show that when patient's glucose levels are managed carefully, the mortality is reduced and the morbidity is reduced too," says Martin Ellmerer, scientific director of the CLINICIP project.

Healthcare staff rely on a technique called 'tight glucose control', also known as 'intensive insulin therapy', which uses insulin to control the glycaemic state of recovering surgical patients. The same method is also used to help patients at medical intensive care units to recover faster.

Key recovery technique
The reason? Glucose effects blood toxicology, so careful management is essential to keep patients in the best possible health.

"This is not just about diabetic patients, though it is important for them too. Glucose management is important, we know for sure, for medical and surgical intensive care patients. It's also important in paediatric intensive care cases. Intensive insulin therapy helps many different kinds of patient to survive or achieve a better recovery," comments Ellmerer.

It is five years since medical science realised how vital glucose control is to ICU outcomes, but there is still no complete solution to glucose management, because it is a very, very difficult problem.

"Taking glucose levels manually is time-consuming, and even when you have accurate, regular data, the impact of glucose levels varies from patient to patient, as does the dose of insulin required. It's a very complex problem, one that seems to be even more complex in critical illnesses than in diabetes management" Ellmerer says.

Automated insulin delivery
Enter CLINICIP, aka the Closed Loop INsulin Infusion for Critically Ill Patients. Ultimately, the project hopes to develop an intelligent, automated glucose monitoring and control system for ICUs. It's called 'closed-loop' because monitoring glucose levels and administering insulin would be completed by one self-contained system.

A closed-loop system needs inputs, analysis and outputs. The CLINICIP partners are developing a system that links glucose measurement to a control unit that assesses a patient's needs, and then releases insulin into a saline drip automatically.

They have already developed an algorithm to analyse how much insulin is needed, based on carbohydrate intake and current glucose levels. The team believe they have solved the problem, but it will require long-term validation to get the correct fine-tuning. That algorithm is in trials, and the partners hope to have initial results early next year.

"We are now testing the algorithm, which could be commercialised as a diagnostic support tool," says Ellmerer.

Internal or external glucose sensors?
The project is also currently studying sensor systems, both intra-vascular and extra-vascular – that is, within and outside the veins. If successful, automated sensor systems could greatly improve the survival chances of intensive care patients. They could also increase efficiency in clinical practice. That, however, is a long-term goal.

On the glucose sensor system, Ellmerer notes that, "Ideally we would like to use a sensor outside of the blood vessels. It's less invasive, and evidence suggests that it can provide a very accurate indication of real glucose levels in the blood."

But first the team must establish that the external sensor is accurate and reliable. The intravascular system is both accurate and reliable, but it is more invasive and time consuming, and not really appropriate for some types of patient such as cardiac arrest victims and infants.

The body interface obstacle
The major obstacle currently facing the project is the body interface, or how the sensor in the body links to the rest of the closed-loop system. Ellmerer says that the team would be interested in hearing from any industrial partners involved in this area.

Even if the body interface problem is solved soon, he believes the full closed-loop system will not be developed within the lifetime of the project, which ends in January 2008. The work will continue however. "There are bilateral agreements between many of the partners to continue the work that we've started here after the life of the project," Ellmerer remarks.

In the meantime, CLINICIP's algorithm has provoked intense interest among medical scientists, and there have been calls to make the algorithm available to all ICUs.

"But it's just not possible yet. We haven't established definitively that it is sufficiently accurate, reliable and safe," warns Ellmerer. "That assessment is under way now."

Contact:
Dr Martin Ellmerer
Medical University Graz
Department of Internal Medicine
Stiftingtalstraße 24
A-8010 Graz
Austria
Tel: +43 316 385 72806
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...